These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35587158)

  • 1. Copper-Catalyzed Oxidative [3 + 2]-Annulation of Quinoxalin-2(1
    Yadav A; Yadav A; Tripathi S; Dewaker V; Kant R; Yadav PN; Srivastava AK
    J Org Chem; 2022 Jun; 87(11):7350-7364. PubMed ID: 35587158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper-Catalyzed Annulation of Oxime Acetates with α-Amino Acid Ester Derivatives: Synthesis of 3-Sulfonamido/Imino 4-Pyrrolin-2-ones.
    Miao CB; Zheng AQ; Zhou LJ; Lyu X; Yang HT
    Org Lett; 2020 May; 22(9):3381-3385. PubMed ID: 32282212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of protein misfolding and aggregation by steroidal quinoxalin-2(1H)-one and their molecular docking studies.
    Iqbal A; Alam MT; Khan A; Siddiqui T; Ali A
    Int J Biol Macromol; 2024 Jun; 269(Pt 1):132020. PubMed ID: 38704061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper-catalyzed [4+2] oxidative annulation of α,β-unsaturated ketoxime acetates with ethyl trifluoropyruvate.
    Yan H; Xu G; Gu M; Zhang S; Wu Q; Meng J; Zhu N; Fang Z; Duan J; Guo K
    Chem Commun (Camb); 2022 Jun; 58(47):6757-6760. PubMed ID: 35611963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diastereoselective [3 + 2] Cycloaddition of Quinoxalin-2(1
    Dutta HS; Ahmad A; Khan AA; Kumar M; Raziullah ; Vaishnav J; Gangwar M; Ampapathi RS; Koley D
    J Org Chem; 2021 Dec; 86(23):16558-16572. PubMed ID: 34780178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinoxalin-2(1H)-one derivatives as inhibitors against hepatitis C virus.
    Liu R; Huang Z; Murray MG; Guo X; Liu G
    J Med Chem; 2011 Aug; 54(16):5747-68. PubMed ID: 21761853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of [1,2,3]triazolo[1,5-a]quinoxalin-4(5H)-ones through copper-catalyzed tandem reactions of N-(2-haloaryl)propiolamides with sodium azide.
    Yan J; Zhou F; Qin D; Cai T; Ding K; Cai Q
    Org Lett; 2012 Mar; 14(5):1262-5. PubMed ID: 22335274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper-catalyzed C-3 benzylation of quinoxalin-2(1
    Xie D; Tian RG; Zhang XT; Tian SK
    Org Biomol Chem; 2022 Jun; 20(22):4518-4521. PubMed ID: 35604002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a novel class of c-Jun N-terminal kinase inhibitors.
    Schepetkin IA; Kirpotina LN; Khlebnikov AI; Hanks TS; Kochetkova I; Pascual DW; Jutila MA; Quinn MT
    Mol Pharmacol; 2012 Jun; 81(6):832-45. PubMed ID: 22434859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palladium(II)-catalyzed oxidative arylation of quinoxalin-2(1H)-ones with arylboronic acids.
    Carrër A; Brion JD; Messaoudi S; Alami M
    Org Lett; 2013 Nov; 15(21):5606-9. PubMed ID: 24117215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and photoinduced DNA cleavage studies of [1,2,4]-triazolo[4,3-a]quinoxalin-4(5H)-ones.
    Sumran G; Aggarwal R; Mittal A; Aggarwal A; Gupta A
    Bioorg Chem; 2019 Jul; 88():102932. PubMed ID: 31028990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.
    Schepetkin IA; Khlebnikov AI; Potapov AS; Kovrizhina AR; Matveevskaya VV; Belyanin ML; Atochin DN; Zanoza SO; Gaidarzhy NM; Lyakhov SA; Kirpotina LN; Quinn MT
    Eur J Med Chem; 2019 Jan; 161():179-191. PubMed ID: 30347329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copper-Catalyzed Divergent C-H Functionalization Reaction of Quinoxalin-2(1
    Yang G; Xiong Z; Nie H; He M; Feng Q; Li X; Huang H; Wang S; Ji F; Jiang G
    Org Lett; 2022 Mar; 24(9):1859-1864. PubMed ID: 35225627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and identification of the intermediates during pyrazole formation of some carbohydrate hydrazone derivatives.
    Awad LF
    Carbohydr Res; 2000 May; 326(1):34-42. PubMed ID: 16001504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11
    Liakhov SA; Schepetkin IA; Karpenko OS; Duma HI; Haidarzhy NM; Kirpotina LN; Kovrizhina AR; Khlebnikov AI; Bagryanskaya IY; Quinn MT
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper-catalyzed cascade syntheses of 2H-benzo[b][1,4]thiazin-3(4H)-ones and quinoxalin-2(1H)-ones through capturing S and N atom respectively from AcSH and TsNH(2).
    Chen D; Wang ZJ; Bao W
    J Org Chem; 2010 Aug; 75(16):5768-71. PubMed ID: 20666413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of quinoxalin-2(1
    Hao X; Qin X; Zhang X; Ma B; Qi G; Yu T; Han Z; Zhu C
    Future Med Chem; 2019 Dec; 11(23):2989-3004. PubMed ID: 31659919
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and excitatory amino acid pharmacology of a series of heterocyclic-fused quinoxalinones and quinazolinones.
    McQuaid LA; Smith EC; South KK; Mitch CH; Schoepp DD; True RA; Calligaro DO; O'Malley PJ; Lodge D; Ornstein PL
    J Med Chem; 1992 Sep; 35(18):3319-24. PubMed ID: 1382133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and molecular docking study of novel quinoxalin-2(1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their cyclooxygenase-2 activity.
    Galal SA; Khairat SH; Ragab FA; Abdelsamie AS; Ali MM; Soliman SM; Mortier J; Wolber G; El Diwani HI
    Eur J Med Chem; 2014 Oct; 86():122-32. PubMed ID: 25147154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palladium-catalyzed oxidative amidation of quinoxalin-2(1H)-ones with acetonitrile: a highly efficient strategy toward 3-amidated quinoxalin-2(1H)-ones.
    Yuan J; Liu S; Xiao Y; Mao P; Yang L; Qu L
    Org Biomol Chem; 2019 Jan; 17(4):876-884. PubMed ID: 30628609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.